Literature DB >> 33573608

High-intensity interval training and energy management education, compared with moderate continuous training and progressive muscle relaxation, for improving health-related quality of life in persons with multiple sclerosis: study protocol of a randomized controlled superiority trial with six months' follow-up.

Nadine Patt1, Jan Kool2, Ruth Hersche3, Max Oberste4, David Walzik5, Niklas Joisten5, Daniel Caminada6, Francesca Ferrara6, Roman Gonzenbach2, Claudio Renato Nigg7, Christian Philipp Kamm8,9, Philipp Zimmer5, Jens Bansi2.   

Abstract

BACKGROUND: Persons with multiple sclerosis (PwMS) often have reduced aerobic capacity and report fatigue as the most disabling symptom impacting their health-related quality of life (HRQoL). A multidisciplinary rehabilitation approach is recommended for successful management of symptoms, although there is little supporting evidence. The aim of this study is to evaluate the effect of a multimodal therapy approach, including endurance training and patient education, during a three-week inpatient rehabilitation stay, on HRQoL in PwMS at six months follow-up. Inpatient energy management education (IEME) + high-intensity interval training (HIIT) will be compared with progressive muscle relaxation (PMR) + moderate continuous training (MCT).
METHODS: This study has a two-armed single-blind randomized controlled superiority trial design. One hundred six PwMS-related fatigue (relapsing-remitting or chronic progressive phenotypes; Expanded Disability Status Scale (EDSS) ≤ 6.5) will be recruited at the Valens clinic, Switzerland, and randomized into either an experimental (EG) or a control group (CG). EG: participants will perform IEME twice and HIIT three times per week during the three-week rehabilitation stay. IEME is a group-based intervention, lasting for 6.5 h over three weeks. HIIT contains of five 1.5-min high-intensive exercise bouts on a cycle ergometer at 95-100% of peak heart rate (HRpeak), followed by active breaks of unloaded pedalling for 2 min to achieve 60% of HRpeak. CG: participants will perform PMR twice and MCT three times per week during the three-week rehabilitation stay, representing local usual care. PMR consists of six 1-h relaxation group sessions. MCT consists of 24-min continuous cycling at 65% of HRpeak. The primary outcome is HRQoL (Physical and Mental Component Summaries of the Medical Outcome Study 36-item Short Form Health Survey; SF-36), measured at entry to the clinic (baseline, T0), three weeks after T0 (T1) and at four (T2) and six (T3) months after T0. Secondary outcomes comprise cardiorespiratory fitness, inflammatory markers (measured at T0 and T1), fatigue, mood, self-efficacy, occupational performance, physical activity (measured at T0, T1, T2 and T3) and behaviour changes in energy management (measured at T2 and T3). DISCUSSION: This study will provide detailed information on a multimodal therapy approach to further improve rehabilitation for PwMS. TRIAL REGISTRATION: This trial was prospectively registered at ClinicalTrials.gov ( NCT04356248 ; 22 April 2020).

Entities:  

Keywords:  Energy management education; Exercise; Fatigue; High-intensity interval training; Inflammation; Multidisciplinary rehabilitation; Multiple sclerosis; Occupational therapy; Quality of life

Mesh:

Year:  2021        PMID: 33573608      PMCID: PMC7877079          DOI: 10.1186/s12883-021-02084-0

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  42 in total

1.  Psychometric evaluation of the Energy Conservation Strategies Survey.

Authors:  Priyanka S Mallik; Marcia Finlayson; Virgil Mathiowetz; Louis Fogg
Journal:  Clin Rehabil       Date:  2005-08       Impact factor: 3.477

2.  A simple sample size formula for analysis of covariance in randomized clinical trials.

Authors:  George F Borm; Jaap Fransen; Wim A J G Lemmens
Journal:  J Clin Epidemiol       Date:  2007-06-06       Impact factor: 6.437

3.  Physical activity and multiple sclerosis: validity of self-report and objective measures.

Authors:  Jessica L Gosney; Jennifer A Scott; Erin M Snook; Robert W Motl
Journal:  Fam Community Health       Date:  2007 Apr-Jun

4.  High-intensity interval training reduces neutrophil-to-lymphocyte ratio in persons with multiple sclerosis during inpatient rehabilitation.

Authors:  Niklas Joisten; Sebastian Proschinger; Annette Rademacher; Alexander Schenk; Wilhelm Bloch; Clemens Warnke; Roman Gonzenbach; Jan Kool; Jens Bansi; Philipp Zimmer
Journal:  Mult Scler       Date:  2020-09-03       Impact factor: 6.312

5.  Use and perceived effectiveness of energy conservation strategies for managing multiple sclerosis fatigue.

Authors:  Kathleen Matuska; Virgil Mathiowetz; Marcia Finlayson
Journal:  Am J Occup Ther       Date:  2007 Jan-Feb

6.  Exercise barriers and preferences among women and men with multiple sclerosis.

Authors:  Miho Asano; Pierre Duquette; Ross Andersen; Yves Lapierre; Nancy E Mayo
Journal:  Disabil Rehabil       Date:  2013-03       Impact factor: 3.033

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

Review 9.  High intensity interval training for people with multiple sclerosis: A systematic review.

Authors:  Evan Campbell; Elaine H Coulter; Lorna Paul
Journal:  Mult Scler Relat Disord       Date:  2018-06-13       Impact factor: 4.339

Review 10.  Rehabilitation in Multiple Sclerosis: A Systematic Review of Systematic Reviews.

Authors:  Fary Khan; Bhasker Amatya
Journal:  Arch Phys Med Rehabil       Date:  2016-05-20       Impact factor: 3.966

View more
  1 in total

1.  Physical Fitness Recovery of Athletes Based on High-Intensity Sports Intermittent Training.

Authors:  Ruihua He; Xiwen Yang; Ligang Ma
Journal:  Biomed Res Int       Date:  2022-07-26       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.